Ellen W Seely1,2, Ann C Celi2,3, Jaimie Chausmer4, Cornelia Graves5, Sarah Kilpatrick6, Jacinda M Nicklas7, Mary L Rosser8, Kathryn M Rexrode2,9, Jennifer J Stuart2,9,10, Eleni Tsigas11, Jennifer Voelker11, Carolyn Zelop12,13, Janet W Rich-Edwards2,9,10. 1. Division of Endocrinology, Hypertension & Diabetes, Brigham and Women's Hospital, Boston, Massachusetts, USA. 2. Harvard Medical School, Boston, Massachusetts, USA. 3. Division of General Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. 4. Maternal Heart Health Clinic, Northside Hospital, Atlanta, Georgia, USA. 5. Collaborative Perinatal Cardiac Center, St. Thomas Health, Nashville, Tennessee, USA. 6. Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California, USA. 7. Division of General Internal Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA. 8. Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York, USA. 9. Division of Women's Health, Brigham and Women's Hospital, Boston, Massachusetts, USA. 10. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. 11. The Preeclampsia Foundation, Melbourne, Florida, USA. 12. The Valley Hospital, Ridgewood, New Jersey, USA. 13. Department of Obstetrics and Gynecology, New York University School of Medicine, New York, New York, USA.
Abstract
Background: Preeclampsia predicts future cardiovascular disease (CVD) yet few programs exist for post-preeclampsia care. Methods: The Health after Preeclampsia Patient and Provider Engagement Network workshop was convened at the Radcliffe Institute for Advanced Study in June 2018. The workshop sought to identify: 1) patient perspectives on barriers and facilitators to CVD risk reduction; 2) clinical programs specialized in post-preeclampsia care; 3) recommendations by national organizations for risk reduction; and 4) next steps. Stakeholders included the Preeclampsia Foundation, patients, clinicians who had initiated CVD risk reduction programs for women with prior preeclampsia, researchers, and national task force members. Results: Participants agreed there is insufficient awareness and action to prevent CVD after preeclampsia. Patients suggested a clinician checklist to ensure communication of CVD risks, enhanced training for clinicians on the link between preeclampsia and CVD, and a post-delivery appointment with a clinician knowledgeable about this link. Clinical programs primarily served patients in the first postpartum year, bridging obstetrical and primary care. They recommended CVD risk modification with periodic blood pressure, weight, lipid and diabetes screening. Barriers included the paucity of programs designed for this population and gaps in insurance coverage after delivery. The American Heart Association, the American College of Obstetricians and Gynecologists, and the Preeclampsia Foundation have developed guidelines and materials for patients and providers to guide management of women with prior preeclampsia. Conclusions: Integrated efforts of patients, caregivers, researchers, and national organizations are needed to improve CVD prevention after preeclampsia. This meeting's recommendations can serve as a resource and catalyst for this effort.
Background: Preeclampsia predicts future cardiovascular disease (CVD) yet few programs exist for post-preeclampsia care. Methods: The Health after Preeclampsia Patient and Provider Engagement Network workshop was convened at the Radcliffe Institute for Advanced Study in June 2018. The workshop sought to identify: 1) patient perspectives on barriers and facilitators to CVD risk reduction; 2) clinical programs specialized in post-preeclampsia care; 3) recommendations by national organizations for risk reduction; and 4) next steps. Stakeholders included the Preeclampsia Foundation, patients, clinicians who had initiated CVD risk reduction programs for women with prior preeclampsia, researchers, and national task force members. Results: Participants agreed there is insufficient awareness and action to prevent CVD after preeclampsia. Patients suggested a clinician checklist to ensure communication of CVD risks, enhanced training for clinicians on the link between preeclampsia and CVD, and a post-delivery appointment with a clinician knowledgeable about this link. Clinical programs primarily served patients in the first postpartum year, bridging obstetrical and primary care. They recommended CVD risk modification with periodic blood pressure, weight, lipid and diabetes screening. Barriers included the paucity of programs designed for this population and gaps in insurance coverage after delivery. The American Heart Association, the American College of Obstetricians and Gynecologists, and the Preeclampsia Foundation have developed guidelines and materials for patients and providers to guide management of women with prior preeclampsia. Conclusions: Integrated efforts of patients, caregivers, researchers, and national organizations are needed to improve CVD prevention after preeclampsia. This meeting's recommendations can serve as a resource and catalyst for this effort.
Entities:
Keywords:
cardiovascular disease; maternal health; preeclampsia; pregnancy complications; preventive health care
Authors: David B Sarwer; Kelly C Allison; Lauren M Gibbons; Jessica Tuttman Markowitz; Deborah B Nelson Journal: J Womens Health (Larchmt) Date: 2006 Jul-Aug Impact factor: 2.681
Authors: Sonia M Grandi; Kristian B Filion; Sarah Yoon; Henok T Ayele; Carla M Doyle; Jennifer A Hutcheon; Graeme N Smith; Genevieve C Gore; Joel G Ray; Kara Nerenberg; Robert W Platt Journal: Circulation Date: 2019-02-19 Impact factor: 29.690
Authors: Luisa Caropreso; Taiane de Azevedo Cardoso; Maha Eltayebani; Benicio N Frey Journal: Arch Womens Ment Health Date: 2019-12-04 Impact factor: 3.633
Authors: Heike Roth; Veronica Morcos; Lynne M Roberts; Lisa Hanley; Caroline S E Homer; Amanda Henry Journal: BMJ Open Date: 2022-05-26 Impact factor: 3.006
Authors: Christina M Ackerman-Banks; Olga Grechukhina; Erica Spatz; Lisbet Lundsberg; Josephine Chou; Graeme Smith; Victoria R Greenberg; Uma M Reddy; Xiao Xu; Jane O'Bryan; Shelby Smith; Lauren Perley; Heather S Lipkind Journal: J Am Heart Assoc Date: 2022-04-12 Impact factor: 6.106
Authors: Mara E Murray Horwitz; Molly A Fisher; Christine A Prifti; Janet W Rich-Edwards; Christina D Yarrington; Katharine O White; Tracy A Battaglia Journal: J Gen Intern Med Date: 2022-01-06 Impact factor: 5.128
Authors: Rianne C Bijl; Sophie E Bangert; Raj Shree; Alina N Brewer; Norlisa Abrenica-Keffer; Eleni Z Tsigas; Maria P H Koster; Ellen W Seely Journal: BMJ Open Date: 2022-03-03 Impact factor: 2.692